BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC
188 results:

  • 1. Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients.
    Schmälter AK; Ngoya M; Galimard JE; Bazarbachi A; Finke J; Kröger N; Bornhäuser M; Stelljes M; Stölzel F; Tischer J; Schroeder T; Dreger P; Blau IW; Savani B; Giebel S; Esteve J; Nagler A; Schmid C; Ciceri F; Mohty M
    Blood Cancer J; 2024 May; 14(1):76. PubMed ID: 38697960
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
    Myers RM; Devine K; Li Y; Lawrence S; Leahy AB; Liu H; Vernau L; Callahan C; Baniewicz D; Kadauke S; McGuire R; Wertheim GB; Kulikovskaya I; Gonzalez VE; Fraietta JA; DiNofia AM; Hunger SP; Rheingold SR; Aplenc R; June CH; Grupp SA; Wray L; Maude SL
    Blood Adv; 2024 May; 8(9):2182-2192. PubMed ID: 38386999
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
    Visentin A; Chatzikonstantinou T; Scarfò L; Kapetanakis A; Demosthenous C; Karakatsoulis G; Minga E; Chamou D; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Besikli-Dimou S; Bron D; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Collado R; Gentile M; Gimeno E; Glenthøj A; da Silva MG; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Rigolin GM; Ruchlemer R; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Tadmor T; Capasso A; Del Poeta G; Gutwein O; Karlsson LK; Milosevic I; Mirás F; Reda G; Saghumyan G; Shrestha A; Te Raa D; Tonino SH; Van Der Spek E; van Gelder M; van Kampen R; Wasik-Szczepanek E; Wróbel T; Segundo LYS; Yassin M; Pocali B; Vandenberghe E; Iyengar S; Varettoni M; Vitale C; Coscia M; Rambaldi A; Montserrat E; Cuneo A; Stavroyianni N; Trentin L; Stamatopoulos K; Ghia P
    Am J Hematol; 2023 Dec; 98(12):1856-1868. PubMed ID: 37772428
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cyld stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
    Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
    PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of Vinblastine and Vincristine on the function of chronic myeloid leukemic cells through expression of A20 and cyld.
    Hoang NH; Huyen NT; Trang DT; Canh NX; Mao CV; Sopjani M; Vuong NB; Xuan NT
    Cell Mol Biol (Noisy-le-grand); 2022 Sep; 68(10):47-53. PubMed ID: 37114273
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Total Marrow Irradiation for Second Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Advanced Acute leukemia.
    Dominietto A; Vagge S; di Grazia C; Bregante S; Raiola AM; Varaldo R; Gualandi F; Gusinu M; Barra S; Agostinelli S; Angelucci E; Hui S
    Transplant Cell Ther; 2023 Aug; 29(8):506.e1-506.e6. PubMed ID: 37094701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.
    Ferrari LC; Rivas MM; Navickas AB; Dick H; Mela Osorio MJ; Agamennoni L; Rey IH; Carnelutto NE; Cazap N; Castro MB; Aranguren PN; Fischman LA; Yupanki ML; Milone JH; Fernández II; Moirano MM; Belli CB;
    Ann Hematol; 2023 May; 102(5):1087-1097. PubMed ID: 36892593
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Isolation of Some Phenolic Compounds from Plantago subulata L. and Determination of Their Antidiabetic, Anticholinesterase, Antiepileptic and Antioxidant Activity.
    Özaslan MS; Sağlamtaş R; Demir Y; Genç Y; Saraçoğlu İ; Gülçin İ
    Chem Biodivers; 2022 Aug; 19(8):e202200280. PubMed ID: 35796520
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
    Salmon M; White HE; Zizkova H; Gottschalk A; Motlova E; Cerveira N; Colomer D; Coriu D; Franke GN; Gottardi E; Izzo B; Jurcek T; Lion T; Schäfer V; Venturi C; Vigneri P; Zawada M; Zuna J; Hovorkova L; Koblihova J; Klamova H; Markova MS; Srbova D; Benesova A; Polivkova V; Zackova D; Mayer J; Roeder I; Glauche I; Ernst T; Hochhaus A; Polakova KM; Cross NCP
    Leukemia; 2022 Jul; 36(7):1879-1886. PubMed ID: 35676453
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mouse models of graft-versus-host disease.
    Patel DA; Schroeder MA; Choi J; DiPersio JF
    Methods Cell Biol; 2022; 168():41-66. PubMed ID: 35366991
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Immune Underpinnings of Barrett's-Associated Adenocarcinogenesis: a Retrial of Nefarious Immunologic Co-Conspirators.
    Tambunting L; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1297-1315. PubMed ID: 35123116
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma.
    Carr RA; Hsu M; Harrington CA; Tan KS; Bains MS; Bott MJ; Ilson DH; Isbell JM; Janjigian YY; Maron SB; Park BJ; Rusch VW; Sihag S; Wu AJ; Jones DR; Ku GY; Molena D
    Ann Surg; 2023 Mar; 277(3):e538-e544. PubMed ID: 34387205
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer.
    Sun L; Patai ÁV; Hogenson TL; Fernandez-Zapico ME; Qin B; Sinicrope FA
    Oncogene; 2021 Aug; 40(32):5105-5115. PubMed ID: 34193942
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling.
    Surman DR; Xu Y; Lee MJ; Trepel J; Brown K; Ramineni M; Splawn TG; Diggs LP; Hodges HC; Davis JL; Lee HS; Burt BM; Ripley RT
    Mol Cancer Ther; 2021 Aug; 20(8):1469-1480. PubMed ID: 34088830
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Intestinal protozoan infections among Egyptian neutropenic patients with acute leukemia.
    Zaki NE; Hamed NA; Sadek NA; Mishriky RI; Abd El-Latif NF; Mikhael IL
    Trop Biomed; 2021 Mar; 38(1):50-56. PubMed ID: 33797524
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Addition of aprepitant improves acute emesis control in children and adolescents receiving induction chemotherapy for acute myeloid leukaemia: a randomised, open-label trial.
    Sharma A; Ganguly S; C SK; Pillai AS; Dhawan D; Sreenivas V; Bakhshi S
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e156-e162. PubMed ID: 33122168
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
    Uy GL; Aldoss I; Foster MC; Sayre PH; Wieduwilt MJ; Advani AS; Godwin JE; Arellano ML; Sweet KL; Emadi A; Ravandi F; Erba HP; Byrne M; Michaelis L; Topp MS; Vey N; Ciceri F; Carrabba MG; Paolini S; Huls GA; Jongen-Lavrencic M; Wermke M; Chevallier P; Gyan E; Récher C; Stiff PJ; Pettit KM; Löwenberg B; Church SE; Anderson E; Vadakekolathu J; Santaguida M; Rettig MP; Muth J; Curtis T; Fehr E; Guo K; Zhao J; Bakkacha O; Jacobs K; Tran K; Kaminker P; Kostova M; Bonvini E; Walter RB; Davidson-Moncada JK; Rutella S; DiPersio JF
    Blood; 2021 Feb; 137(6):751-762. PubMed ID: 32929488
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
    Candoni A; Farina F; Perruccio K; Di Blasi R; Criscuolo M; Cattaneo C; Delia M; Zannier ME; Dragonetti G; Fanci R; Martino B; Del Principe MI; Fianchi L; Vianelli N; Chierichini A; Garzia M; Petruzzellis G; Nadali G; Verga L; Busca A; Pagano L
    Mycoses; 2020 Oct; 63(10):1094-1100. PubMed ID: 32697010
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MALT-1 as a novel therapeutic target for adult T-cell leukemia.
    Ishikawa C; Mori N
    Eur J Haematol; 2020 Oct; 105(4):460-467. PubMed ID: 32574386
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Reversal of cyld phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
    Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
    Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.